Weigao Holding Company Limited. ("Weigao Holding") and together with its subsidiaries ("Weigao") is situated in Weihai City, a picturesque coastal city in China. Weigao Holding has 18 subsidiaries and has more than 9,000 employees and a total asset value of over RMB 4 billion (approximately US$0.59 billion). Shandong Weigao Group Medical Polymer Company Limited ("Weigao Group"), the major subsidiary of Weigao Holding, was listed on the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited in 2004. Weigao covers a manufacturing area of 1,250,000 square meters including sterilized workshops with an area of 200,000 square meters that comply with GMP standards. It currently produces more than 250 types of medical products with more than 30,000 specifications.In the past 20 years, Weigao rooted with the spirit of "development, innovation, pragmatism and consolidation", and dedicated to attract talented people from the communities. Weigao focuses on technology driven innovative ideas and scientific management to transform the development mode and to advance the healthy and efficient growth of the business. In the domestic market, the company was the early mover to initiate the products of single use transfusion sets, medical suture, implantable medical catheters, coronary stents, intravenous catheters, irregular needles, blood purification, orthopaedic, electronic and mechanical medical products, medical injection fluid products, diagnostic reagents, artificial blood plasma and various medical products and medications. Weigao has established very large manufacturing bases in China for medical consumables, orthopaedic products, pharmaceuticals,and aerospace products. Today, Weigao is the leading single use medical consumable manufacturer in China. Weigao established the mode of scientific management to achieve a smooth operation system. It is the first company in the industry to introduce and to successfully establish the management system of enterprise resource planning (ERP), key performance indicators (KPI) and other management system. Weigao Holding obtained the certifications of Conformité Européene (CE), ISO9000, ISO13485, China Compulsory Certification; and products registration of FDA 510K from Food and Drug Association (FDA). The award accredited to testing and inspection center of the company is also the only certification issued by China National Accreditation Board for Lab oratories in industry.
more >
Year of Establishment:
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
Other Competitive Advantages:
Patents and Copyrights: